- Home
- IPHA vs QIPT Comparison
IPHA vs QIPT Comparison
Compare IPHA & QIPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | IPHA | QIPT |
|---|---|---|
| Founded | 1999 | 1993 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 174.2M | 157.2M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | IPHA | QIPT |
|---|---|---|
| Price | $1.70 | $3.59 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $5.00 | $3.83 |
| AVG Volume (30 Days) | 26.6K | ★ 559.9K |
| Earning Date | 09-17-2025 | 02-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $14,839,695.00 | ★ $245,359,000.00 |
| Revenue This Year | $22.29 | $28.30 |
| Revenue Next Year | $43.90 | $1.79 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.63 | $1.35 |
| 52 Week High | $2.63 | $3.61 |
Technical Indicators
Market Signals| Indicator | IPHA | QIPT |
|---|---|---|
| Relative Strength Index (RSI) | 46.43 | 80.73 |
| Support Level | $1.72 | $3.52 |
| Resistance Level | $1.86 | $3.54 |
| Average True Range (ATR) | 0.08 | 0.02 |
| MACD | 0.01 | -0.04 |
| Stochastic Oscillator | 39.39 | 75.00 |
Price Performance
Historical ComparisonAbout IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About QIPT Quipt Home Medical Corp.
Quipt Home Medical Corp is a provider of durable medical equipment (DME) and home medical equipment (HME) in the United States. The Company specializes in delivering in-home treatments for the management of chronic conditions, with a primary focus on respiratory diseases, and supports patients with heart and pulmonary diseases, sleep apnea, reduced mobility, and other chronic health challenges. Its products and services include Sleep Apnea and PAP treatment, home medical equipment, home ventilation, and custom mobility solutions. The Company operates in a single business segment, comprising the sale and rental of medical equipment and related devices, and serves patients across 27 states in the United States.